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Abstract
The tumour promoter, phorbol ester 12,13-dibutyrate (PDBu), acts on rectal palisadic epithelial cells and mimics the
effects of neuroparsin, an antidiuretic neuronal hormone isolated from nervous lobes of the African locust corpora cardiaca.
PDBu stimulated Ca2-dependent phospholipase C (PLC) activity resulting in inositol 1,4,5-trisphosphate (Ins1;4;5P3)
production, increased cytosolic free calcium (monitored with the probe indo-1) and rectal fluid resorption. A 15-min pre-
treatment with polymyxin B (PMXB), a protein kinase C (PKC) inhibitor acting at the phosphatidylserine (PS) binding site,
suppressed PDBu stimulatory effects on free calcium entry and fluid resorption but not on phosphatidylinositol
4,5-bisphosphate (PtdIns-4,5-P2) breakdown. On the contrary, bisindolylmaleimide Ro 32-0432 (which inhibits PKC at its
ATP binding site) abolished entirely PDBu-stimulated PLC activity. It was concluded that two PKC are involved in
transduction of the antidiuretic signal of neuroparsin. One PKC is PMXB sensitive and stimulates biological response after
cytosolic free Ca2 increase, while another PKC, insensitive to the PKC inhibitor, regulates the processes induced by the
former PKC. Since PMXB-insensitive PKC exerts a stimulatory effect on PtdIns-4,5-P2-PLC production, this original
mechanism may be considered as a new signalling pathway under control of PKC. ß 1999 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Hormones or neurotransmitters which stimulate
membrane e¡ector PLC induce then PtdIns-4,5-P2
breakdown [1^3], resulting in production of two sec-
ond messengers: Ins1;4;5P3 which facilitates Ca2
release from internal stores, and diacylglycerol
(DAG) which activates phosphatidylserine (PS) and
Ca2-dependent PKC. PKC isozymes [4] catalyse in
turn numerous protein phosphorylations which are
essential signalling steps for cellular activation and
subsequent biological responses.
The potent tumour promoters, phorbol esters,
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Abbreviations: [Ca2]i, cytosolic free Ca2 concentration;
DAG, diacylglycerol; GPI, glycerophosphorylinositols ; InsPs,
inositol phosphates; Ins1P1, inositol 1-monophosphate;
Ins4P1, inositol 4-monophosphate; Ins1;3P2, inositol 1,3-bis-
phosphate; Ins1;4P2, inositol 1,4-bisphosphate; Ins1;3;4P3, ino-
sitol 1,3,4-trisphosphate; Ins1;4;5P3, inositol 1,4,5-trisphosphate;
Ins1;3;4;5P4, inositol 1,3,4,5-tetrakisphosphate; Nif, nifedipine;
NP, neuroparsin; PDBu, phorbol ester dibutyrate; PtdIns, phos-
phatidylinositol ; PtdIns-4-P, phosphatidylinositol 4-monophos-
phate; PtdIns-4,5-P2, phosphatidylinositol 4,5-bisphosphate;
PKC, protein kinase C; PLC, phospholipase C; PMA, phorbol
12-myristate 13-acetate; PMXB, polymyxin B sulfate; PS, phos-
phatidylserine; R, ratio F405/F480 re£ecting [Ca2]i ; Ro 32-0432,
bisindolylmaleimide XI hydrochloride
* Corresponding author.
BBAMCR 14500 29-6-99
Biochimica et Biophysica Acta 1450 (1999) 242^253
stimulate PKC by substituting for DAG [5], but
Unc-13 protein [6] and n-chimaerin [7] have
been demonstrated to be phorbol ester receptors.
A fundamental di¡erence between phorbol esters
and DAG has been reported [8,9] : DAG is quickly
metabolised and activates PKC in a transitory
fashion while phorbol esters are stable mole-
cules which activate the enzyme over a longer time
period.
In vertebrate cells, it has been described that either
endogenous DAG or phorbol esters may modulate
phosphoinositide breakdown by activating PKC
[10,11]. PKC exerts negative feedback on PtdIns-
4,5-P2 hydrolysis by phosphorylation of receptors
or GTP-binding proteins. However, in invertebrate
cell types, there are no precise data on regulation
of phosphoinositide turnover by PKC.
In Insects, implication of PKC activity in di¡erent
cellular signalling pathways has been also reported.
As an example, in Aedes aegypti, the enzyme phos-
phorylates Cl3 channel proteins [12]. In African lo-
cust rectum, and especially in palisadic epithelial cells
[13,14], stimulation of PKC is initiated by the anti-
diuretic signal of neuroparsin [15], a neuronal hor-
mone extracted from storage lobes of the corpora
cardiaca [16]. Two di¡erent inositol phosphate
(InsP) cascades were then observed following phos-
phoinositide breakdown [17,18]. One pathway in-
volves phosphatidylinositol (PtdIns) and phosphati-
dylinositol 4-monophosphate (PtdIns-4-P) hydrolysis
under unknown PLC activity, whatever the concen-
tration of neuroparsin. High concentrations of the
agonist induce a second pathway which implicates
pertussis toxin-insensitive heterotrimeric GKq;11 pro-
tein, PtdIns-4,5-P2-PLC activity and complex InsP
turnover. PKC plays a pivotal role by acting on
(1) Ca2 in£ux via the opening of L-type channels
[14], (2) £uid resorption [15], and (3) soluble guanylyl
cyclase activity [19,20] which, ¢nally, down-regulates
Ca2 in£ux.
Another originality observed after PKC stimula-
tion by DAG analogues and phorbol esters, is an
increase in PLC activity, as neuroparsin does [13^
15,18]. However, the di¡erent steps of such a path-
way still remain unknown since previous experiments
performed using Dowex columns did not allow to
separate InsP isomers.
In this study, we analysed the PKC roles exhibited
in both pathways under control of antidiuretic signal
from neuroparsin. We demonstrated a new function
for one PKC, which induced or potentiated PtdIns-
4,5-P2-PLC activity. Investigations were carried out
using PDBu as PKC activator and PMXB as inhib-
itor, a suitable biological assay to measure rectal
£uid resorption, microspectro£uorimetry (and indo-
1 probe) to analyse cytosolic free Ca2 movements,
anion-exchange HPLC to separate InsP isomers, and
binding experiments.
2. Materials and methods
2.1. Insects
We used 15^20-day-old male Locusta migratoria
migratorioides, reared in the laboratory at 30‡C
under crowded conditions, and fed with fresh wheat
and bran [13^20].
2.2. Hormone and chemicals
Neuroparsin was extracted from storage lobes of
the corpora cardiaca or obtained by molecular biol-
ogy tools [15,16], then puri¢ed in the laboratory.
Maximal £uid resorption was generated with a 0.5
gland pair equivalent (0.5 cc), which corresponds to
a concentration of agonist equivalent to 2U1037 M.
Chemicals were purchased from Sigma (St. Louis,
MO, USA): EGTA, EDTA, inositol 1-mono-
phosphate (Ins1P1), inositol 1,4-bisphosphate
(Ins1;4P2), Ins1;4;5P3, inositol 1,3,4,5-tetrakisphos-
phate (Ins1;3;4;5P4), PKC activators (as 1-stearoyl-
arachidonoyl-sn-glycerol (SAG), or phorbol-12-myr-
istate-13-acetate (PMA), or PDBu, PS, and PMXB
sulfate, which inhibits PKC at its regulatory site by
competition with PS [21,22]. Another PKC inhibitor,
Ro 32-0432, which acts at the ATP binding site, was
purchased from Alexis Biochemicals (Roger, Paris,
France). The di¡erent substances were prepared as
stock solutions by dilution in either physiological
medium, or in 0.03% methanol (PDBu, PMA), or
in 0.1% dimethylsulfoxide (SAG, Ro 32-0432), before
suitable dilutions in medium.
D-myo-[2-3H]Inositol (10^20 Ci/mmol), [3H]inositol
polyphosphate marker set (containing Ins1P1,
Ins1;4P2 and Ins1;4;5P3), Ins1;3;4;5P4, InsP6, D-
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myo-[2-3H]Ins1;3;4;5P4; 20^60 Ci/mmol) were pur-
chased from the Radiochemical Centre (Amersham,
UK), while myo-[inositol-2-3H(N)]InsP6 (10^30 Ci/
mmol) was purchased from NEN (DuPont de Nem-
ours, Les Ulis, France).
2.3. In vitro rectal sac preparations
Antidiuretic activity of di¡erent substances was
measured using the biological assay of everted sac
preparations [15]. Brie£y, following a 1-h equilibra-
tion in chloride-free saline (25‡C) derived from the
normal saline of Hanrahan, oxygenated with 95%
O2/5% CO2, rectae were ¢lled with 10 Wl of the nor-
mal saline complemented with neuroparsin or chem-
icals, or not (controls). Organs were incubated for an
additional hour in normal oxygenated medium. Fluid
resorption was measured as Wl/sac per h for each
experimental group, and data were then expressed
as percentages, as compared to controls.
PMXB treatments were performed for 15 min, as
described [14,18]. After washing, rectae were ¢lled
with 10 Wl of normal saline complemented with neu-
roparsin or chemicals, or not (controls). Osmotic
pressures of salines containing the di¡erent drugs
were measured prior to all experiments, and were
equivalent to that of standard saline (425^450 mos-
mol).
2.4. Cytosolic free calcium measurements
After removing and washing, isolated rectae were
cut along their length and placed on rubber disks
(2.5 cm diameter, 0.5 cm height) having a circular
hole (7 mm diameter) in their centre and ¢xed with
small needles, the haemolymph side above. A small
PVC cylinder (0.5 cm diameter, 0.6 cm height) was
then placed on each organ and was introduced into
the hole by gentle pressure while needles were pro-
gressively exited. In these conditions, the luminal side
of the rectum was placed toward the bottom of the
disk and maintained closed by a glass coverslide
which was ¢xed with silicone grease into a perforated
cell culture box (3 cm diameter), as reported [14]. To
prevent drying, 50 Wl of standard saline were added
into the central cavity of the disk delimited by the
PVC cylinder and locust tissues, while 1 ml of the
saline was placed around the disk.
Incorporation of the calcium probe indo-1 was
performed as described [14]. Brie£y, the saline was
changed for similar saline containing 5 WM indo-1
penta-acetoxymethyl ester (indo-1/AM, Calbiochem,
San Diego, CA, USA) and complemented with
0.02% Pluronic F-127 (Molecular Probes, USA).
Rectae were oxygenated and incubated for 30 min
at 20 þ 1‡C. Between two successive stimulations, or-
gans were washed with standard saline, and the ap-
paratus was ¢lled with 50 Wl standard saline before
£uorescence measurements.
Microspectro£uorimetry was carried out at 25‡C
and calcium concentrations were routinely estimated
from indo-1 £uorescence by the ratio method using
single wavelength excitation (355 nm) and dual emis-
sion at 405 nm and 480 nm. Our experiments being
achieved on tissues and not on cultured cells, only
changes in the ratio F405/F480 (R) were recorded, as
discussed [14]. Results were expressed as percentages
of changes in £uorescence intensities as measured in
controls. All conditions and limits (calibration curve,
viability of tissues, etc.) were similar to those previ-
ously reported. At least three or four similar experi-
ments were performed for either stimulation or con-
trol conditions.
2.5. Labelling of inositol lipids
The protocol of everted rectal sac preparations
was used for the phosphoinositide labelling. Rectae
were ¢lled with 10 Wl of Hanrahan’s saline containing
0.2 WCi of myo-[2-3H]inositol and incubated at 25‡C
for 1.5 h. At the end of this period, rectae were
emptied and incubated again with 10 Wl of the
same labelled solution for an additional 1.5-h incu-
bation, since the proportion of the radioactivity ex-
pressed by inositol lipid fraction, as compared to the
total radioactivity, became stable after the third hour
of incubation [18]. This protocol of inositol lipid la-
belling was used before measurements of PLC activ-
ity or anion-exchange HPLC separation of InsP iso-
mers.
2.6. Phospholipase C assay
At the end of the labelling period, tissues were
homogenised [23,24] with a 8 ml Kontes potter in
4 ml Bistris (20 mM, pH 6.5), 0.1 mM EDTA and
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0.15 mM NaCl, at 4‡C. Disrupted tissues were lay-
ered on to a 750 Wl sucrose cushion (27% sucrose in
the lysis bu¡er) and 90-min ultra-centrifuged at
105 000Ug, using a Beckman 55Ti rotor. Membranes
were collected from the sucrose/bu¡er interface, di-
luted with 3.3 ml Bistris (50 mM, pH 6.5), and ultra-
centrifuged at 105 000Ug for 60 min. Pellets were
suspended by gentle homogenisation in 0.1 M Bistris
(pH 6.5), then aliquoted (200 Wl/sample) and stored
at 380‡C prior to utilisation.
Under these conditions of extraction, electronic
microscopy controls revealed that we obtained
vesicles and not opened membranes (data not
shown). Membranes were then 10 min incubated at
37‡C in the presence of di¡erent chemicals and 1 mM
EGTA or 0.1 mM CaCl2, as described [19,25,26].
This optimal CaCl2 concentration allowed to induce
maximal PLC stimulation with 0.5 cc neuroparsin
[18], and in the presence of 15 mM lithium chloride
which prevents inositol monophosphate metabolism.
PMXB treatments were achieved for 15 min before
addition of other molecules, and during the di¡erent
periods of stimulation with either the agonist neuro-
parsin or PKC activators. Reactions were stopped by
rapid cooling on ice. Phosphoinositides and InsPs
were extracted with 1 ml chloroform/methanol/HCl
mixture (1:2:0.02, by vol.). To this was added 350 Wl
of chloroform and 500 Wl of 2 M KCl. Two phases
were separated after each sample was vortex-mixed
then centrifuged for 5 min at 2000Ug, and their ra-
dioactivity was measured in LS 1800 Beckman coun-
ter.
PLC activity was expressed [25] as percentages of
labelled PIs hydrolysed (%H):
%H  R1 dpm
R1 dpm R2 dpmx100
where R1 represents radioactivity from the methanol
phase (inositol plus InsPs), and R2 the radioactivity
detected in chloroform phase (phosphoinositides).
2.7. HPLC separation of InsP isomers
Labelled rectae were rinsed for 5 min with saline to
prevent contaminants and to stabilise basal InsP pro-
duction. After treatments with molecules, InsP ex-
traction was achieved as published [18,24]. Reactions
were stopped by sonicating rectae (pools of 6^8 or-
gans) in 1.5 ml of a solution containing 5 mM
KH2PO4, 10 mM EDTA (pH 6.3), 0.2 Wg each of
myo-inositol, mannitol, phytic acid, and each of the
unlabelled Ins1P1, Ins1;4P2, Ins1;4;5P3 and
Ins1;3;4;5P4 as carriers [25]. Then samples were cen-
trifuged at 10 000Ug for 5 min.
InsP isomer separation was performed on Beck-
man Gold HPLC system using Partisil 10-SAX In-
terchrom anion-exchange column (25U0.46 cm;
10 WM; from Interchim, Montluc,on, France), as de-
scribed [18], and by increasing concentrations in am-
monium formate (pH 3.7) from 0 to 3 M, under
constant £ow rate (1.1 ml/min). To achieve a good
separation of InsP isomers, 0.44 ml fractions were
collected. Standards were separated in the following
order: inositol, glycerophosphorylinositols (GPI),
Ins1P1, Ins1;4P2, Ins1;3;4P3, Ins1;4;5P3 and
Ins1;3;4;5P4. All these substances were detected in
locust rectal tissues as well as two other InsPs pre-
viously identi¢ed as putative inositol 4-monophos-
phate (Ins4P1) and inositol 1,3-bisphosphate
(Ins1;3P2). However, very low recovery of the radio-
activity of standards was recorded after elution
under high concentrations of the mobile phase. To
overcome the problem, fractions corresponding to
low concentrations of elution bu¡er were diluted in
1 ml water while fractions corresponding to high
concentrations were diluted in 4 ml water [18].
Then, 10 ml of scintillation liquid were added to
the samples before counting. Such modi¢cations per-
mitted to recover about 70% of the known radioac-
tivity.
Since stimulation of neuroparsin-induced phos-
phoinositide system did not a¡ect GPI production
(i.e., had no e¡ect on PLA activities), the ratio
GPI/inositol remained constant and values calculated
for each sample aligned perfectly (cf. Pearson’s test)
on a straight line, according to a function Y = aX+b
(where Y represents GPI concentration and X, inosi-
tol level). To correct the variability in size of the
rectal tissues, we expressed the quantity of radioac-
tivity corresponding to each InsP separated using the
following equation [18,25]:
QInsP  dpm InsP
dpm GPIK
GPI
(KGPI = 530, or arbitrary constant value of GPI;
*original radioactivity value).
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2.8. [3H]PDBu binding analysis
Rectae were homogenised in 10 ml of 10 mM
Hepes (pH 7.3) containing 5 mM MgCl2, 1 mM
EGTA and protease inhibitors: 1 mM PMSF, 2 Wg/
ml aprotinin, 0.5 Wg/ml leupeptin, 0.7 Wg/ml pepstatin
[26]. Membranes (700 Wg/ml) were ultra-centrifuged
at 30 000Ug and at 4‡C for 30 min (Ti45 rotor,
Beckman). The pellets were re-suspended in 200 Wl
10 mM Hepes and aliquoted (24 Wg/sample), then
pre-incubated (25‡C) for 15 min with 1000 UI (Sig-
ma) PMXB. [3H]PDBu (NEN) binding experiments
were performed with 5 nM of the PKC activator,
and in the presence of 0.1 mM Ca2. [3H]PDBu
was used on either untreated membranes or
PMXB-treated membranes (in these conditions,
PMXB was kept in the incubation medium). Free
and bound radioactivities were separated by 8-min
centrifugation at 20 000Ug.
2.9. Statistical expression of results
Standard errors were shown in graphs. The stu-
dent t-test was performed to compare control (Ct)
and experimental values: *P6 0.05, **P6 0.01, or
***P6 0.005, respectively, as compared to con-
trols.
3. Results
3.1. E¡ect of PMXB on neuroparsin-induced £uid
resorption
After a 1-h incubation period, 0.5 cc neuroparsin
increased £uid resorption by 100% while 15 min pre-
treatment with 1000 UI (Sigma) PMXB used alone
increased the £uid resorption by 20%, compared to
controls (Fig. 1). When neuroparsin was used after
PMXB pre-treatment, the stimulatory e¡ect of the
agonist was suppressed. A dose-response curve was
achieved with increasing concentrations of PMXB
(Fig. 1B). Since maximum inhibition was recorded
with 1000 UI (Sigma), the concentration was then
used in experiments.
Fig. 1. Changes in £uid resorption, measured on everted rectal
sac preparations, after a 15-min pre-treatment with di¡erent
concentrations of PMXB, and 1 h stimulation by 2U1037 M
neuroparsin (NP), or not (controls). Mean þ S.E. (n = 6^8); sig-
ni¢cant results compared to controls (Ct): *P6 0.05,
**P6 0.01, ***P6 0.005.
Fig. 2. E¡ects of di¡erent PKC activators on £uid resorption.
(A) Rectae were stimulated by either 5U1036 M SAG, 5U1035
M PMA, or 1036 M PDBu, after a 15-min pre-treatment with
1000 UI Sigma PMXB (dashed columns), or not (white col-
umns). (B) Dose-dependent e¡ects of increasing concentrations
of PDBu on biological response. Mean þ S.E. (n = 6^12); signi¢-
cant results compared to controls (Ct): *P6 0.05, **P6 0.01,
***P6 0.005.
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3.2. E¡ects of PKC activators on £uid resorption
Similar stimulation of £uid resorption as did the
agonist, was induced by either 5U1036 M SAG,
5U1035 M PMA, or 1036 M PDBu; but PDBu re-
mained the most e⁄cient PKC activator, able to act
at the lowest concentrations (Fig. 2A). We also dem-
onstrated that enhancement in biological response
depended exclusively on PKC activity since PMXB
abolished e¡ects of activators. A dose^response
curve was obtained with increasing concentrations
of PDBu. Maximum e¡ect occurred with 1 WM
PDBu (Fig. 2B), while a plateau phase was detected
in the presence of higher PDBu concentrations, up to
100 WM.
Similar biological responses were induced in the
presence of either 1 WM PDBu or 80 Wg/ml PS, or
both drugs used simultaneously (Fig. 3A). On the
contrary, £uid resorption dramatically decreased
(Fig. 3B) in the absence of Ca2, i.e., after chelation
with 1.2 mM EGTA.
A 15-min pre-treatment with 1000 UI (Sigma)
PMXB (Fig. 3C) or 50 nM Ro 32-0432 (Fig. 3D)
inhibited the biological response, whatever the drug
used for PKC stimulation, i.e., in the presence of
either 1 WM PDBu, or 80 Wg/ml PS, or 1 WM
PDBu plus 80 Wg/ml PS used together. It was also
observed that Ro 32-0432 did not enhanced £uid
resorption when used alone.
3.3. E¡ects of PDBu on PLC activity
After a 10-min incubation, increasing concentra-
tions of PDBu enhanced PLC activity in microsomes
(Fig. 4A). The dose^response curve obtained with
di¡erent PDBu concentrations resembles curve ob-
Fig. 3. Changes in £uid resorption after a 1-h stimulation with either 1 WM PDBu or 80 Wg/ml PS, or PDBu+PS. Drugs were used
alone (A), with 1.2 mM EGTA (B), or after a 15-min pre-treatment with either 1000 UI Sigma PMXB (C) or 10 nM Ro 32-0432
(D). Mean þ S.E. (n = 7^9); signi¢cant results compared to controls (Ct): *P6 0.05, **P6 0.01.
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tained for £uid resorption in similar conditions.
Superimposition of 80 mg/ml PS treatment to 1 WM
PDBu treatment potentiated weakly but signi¢cantly
PLC activity stimulated by PDBu.
PLC activity signi¢cantly increased in the presence
of 1 WM PDBu and 0.1 mM Ca2 (Fig. 4B). On the
contrary, the divalent cation chelator EGTA pro-
voked a drop in PDBu e¡ect, although the latter still
remained positive and signi¢cant, as compared to
controls.
A 15-min pre-treatment with PMXB did not abol-
ish the stimulatory e¡ects of 1 WM PDBu exhibited
in the presence of 80 Wg/ml PS, or not (Fig. 4C). In
these conditions, PDBu e¡ect surprisingly appeared
di¡erent to that obtained for £uid resorption, under
similar conditions (see Fig. 2A). On the contrary, a
15-min pre-treatment with Ro 32-0432 (50 nM) en-
tirely abolished the stimulation of PLC activity in-
duced by di¡erent chemicals (Fig. 4C).
3.4. E¡ects of PDBu on InsP production
InsP production increased in rectal cells when they
were stimulated with increasing concentrations of
PDBu (Fig. 5A), and a maximum was recorded
with 1 WM PDBu. However, the increase in InsP
production was only obtained after a minimum of
20 s treatment with 1 WM PDBu, but not for a short-
er time (Fig. 5B). InsP production reached a maxi-
mum for 1 min PDBu stimulation. After InsP sepa-
ration by anion-exchange HPLC, PDBu induced
high levels in Ins1P1, Ins4P1, Ins1;3P2, Ins1;4P2,
Ins1;3;4P3 and Ins1;4;5P3.
Addition of 80 Wg/ml PS to 1 WM PDBu provoked
earlier PDBu stimulatory e¡ects (Fig. 5B):
Ins1;4;5P3 production was obtained after a 5-s stim-
ulation period. The highest level in InsP production
was ¢nally observed after 1 min incubation with
PDBu plus PS.
PMXB pre-treatment changed the PDBu e¡ects
(Fig. 5B,E). Ins1P1, Ins4P1, Ins1;4P2, Ins1;3P2 and
Ins1;4;5P3 productions signi¢cantly increased after
20 s stimulation with 1 WM PDBu, while a longer
incubation period (1 min) did not improve the result.
Furthermore, InsP production did not change
after 15 min PMXB pre-treatment then 5 s PDBu
(1 WM) stimulation, in the presence of 80 WM/ml
PS (Fig. 5B,D,F): InsP production remained similar
to that of controls (or PDBu when used alone). On
the contrary, after a PMXB treatment (Fig. 5F), a
longer stimulation (20 s) with both PDBu and PS
resulted in InsP production similar to that induced
in the absence of PMXB treatment. After a 1-min
Fig. 4. Stimulation of PLC activity. (A) E¡ects of increasing
concentrations of PDBu, used alone (white columns) or in the
presence of 80 mg/ml PS (dashed columns). (B) E¡ects of 0.1
mM Ca2 and 1.2 mM EGTA on 1 WM PDBu-stimulated PLC
activity, compared to controls (Ct). (C) E¡ects of pre-treat-
ments with 1000 UI PMXB (dashed columns) or 10 nM Ro 32-
0432 (black columns) on PLC activity stimulated with either
1 WM PDBu or 1 WM PDBu+80 Wg/ml PS. Mean þ S.E. (n = 6^
8); signi¢cant results compared to controls (Ct): *P6 0.05,
**P6 0.01, ***P6 0.005.
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Fig. 5. Separation of InsPs isomers by anion-exchange HPLC. (A) Total InsP production after stimulation with increasing concentra-
tions of PDBu, used alone (white columns) or in the presence of PS (dashed columns). (B) Total InsP production with either PDBu
or PDBu+PS, for di¡erent times, and after PMXB pre-treatment (dashed columns), or not (white columns). (C,D) InsP productions
for di¡erent times after stimulation with PDBu or PDBu+PS, respectively. (E,F) InsPs produced in similar conditions as in C and D,
respectively, but after PMXB pre-treatment. Concentrations of PDBu, PS and PMXB, when used alone, were 1 WM, 80 Wg/ml, and
1000 UI, respectively. Mean þ S.E. (n = 5^10).
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stimulation in similar conditions, Ins1;3P2 and
Ins1;4;5P3 productions further increased.
3.5. E¡ects of PDBu on cytosolic free calcium
movements
Calcium movements were measured in both cate-
gories (palisadic and basal) of epithelial cells. In pal-
isadic cells (Fig. 6A), 1 WM PDBu induced a rise in R
re£ecting [Ca2]i, after a 5-s delay (Fig. 6A-1). This
approximately reached 20%, as compared to basal
level. A return to basal level was recorded after
35 s. Furthermore, a treatment performed with the
L-type Ca2 channel blocker nifedipine (Fig. 6A-2)
provoked a decrease in R. In these conditions, 1 WM
PDBu became not e⁄cient to induce elevation in
R. In other hand, and after 15 min PMXB treatment
(Fig. 6A-3), PDBu (1 WM) e¡ect on R in palisadic
cells was null, i.e., similar to that of controls.
In rectal basal cells (Fig. 6B), 1 WM PDBu induced
a slight increase in R after a 26-s delay (Fig. 6B-1).
Then R returned to the basal level. This e¡ect be-
Fig. 6. Measurement of R re£ecting cytosol free Ca2 concentration in living epithelial rectal cells. The di¡erent substances were
added only when a stable horizontal line was attained for the R record. (A) Stimulation of R palisadic cells with 1 mM PDBu (1), in
the presence of 1 WM of the L-type Ca2 channel inhibitor nifedipine (Nif) or not (2), and after pre-treatment with 1000 UI PMXB
(P) (3). (B) Similar experiments performed in basal cells ; trace 4 corresponds to trace 1, while traces 5 and 6 correspond to traces
2 and 3, respectively.
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came null in the presence of nifedipine (Fig. 6B-2) or
after a pre-treatment with the PKC inhibitor PMXB
(Fig. 6B-3).
3.6. PDBu binding after PMXB treatment
[3H]PDBu binding increased upon a very short in-
cubation period, then it reached a plateau after 10
min. A 15-min treatment with the PKC inhibitor
PMXB provoked a large decrease in [3H]PDBu bind-
ing to microsomes, over a short time incubation pe-
riod (Fig. 7). A longer incubation (10 min) re-estab-
lished similar [3H]PDBu binding as observed in
stimulated controls, i.e., in the absence of PMXB.
However, when incubation time increased to 30
min, [3H]PDBu binding in PMXB-treated micro-
somes decreased again to an intermediate value com-
prised between that recorded at the beginning of the
experiment and that obtained for a 10-min incuba-
tion period.
4. Discussion
This study shows that PDBu, a known potent
PKC activator [5,9], increased (1) cytosolic free
Ca2 levels in palisadic epithelial cells of the African
locust rectum and (2) £uid resorption, as did other
PKC activators (PMA or SAG, a DAG analogue) or
the antidiuretic neuronal hormone neuroparsin [13^
15,17]. Basal epithelial cells of the rectum were
weakly sensitive to PDBu e¡ect while the substance
had no e¡ect on other rectal cells [14]. Furthermore,
PMXB pre-treatment abolished PDBu-induced stim-
ulation of Ca2 in£ux and biological response. Thus,
the data may suggest the involvement of PKC in
both processes, as phorbol ester receptors.
We have reported that neuroparsin, as a function
of its concentration, rapidly (5 s) mobilises two dif-
ferent phosphoinositide pathways in palisadic epithe-
lial cells of the locust rectum through involvement of
two di¡erent Ca2-dependent PLC activities [18].
One pathway starts from PLC activity which hydrol-
yses lowly phosphorylated substrates (PtdIns or
PtdIns-4-P) and produces Ins1P1, or Ins1;4P2
then Ins4P1, respectively, whatever the concentra-
tion of neuroparsin. High concentrations of the ago-
nist activate PtdIns-4,5-P2-PLC and Ins1;4;5P3 pro-
duction. Both PLC activities induced by neuroparsin
are inhibited after a 15-min PMXB treatment [13,18].
In this study, we demonstrated that PDBu also
stimulated Ca2-dependent PLC activity and in-
creased an early (5 s) Ins1;4;5P3 production, and
the phospholipid PS accelerated and enhanced
PDBu e¡ect (Fig. 5). However, a major di¡erence
exists between e¡ects of PDBu and neuroparsin since
PDBu did not stimulate an early (5^20 s) Ins1P1
production and because Ins1;4P2 and Ins4P1 sig-
ni¢cantly increased from 20 s to 1 min of incubation.
PtdIns/PtdIns-4-P-PLC activity being not e⁄cient
before 20 s, data indicate a preferential e¡ect of
PDBu on the phosphoinositide pathway implicating
PtdIns-4,5-P2-PLC activity (i.e., Ins1;4;5P3 produc-
tion at 5 s). Production of Ins1;4P2 and Ins4P1
observed at 20 s without any change in Ins1P1 cor-
responds to the e¡ects of monophosphatases which
hydrolysed Ins1;4;5P3, Ins1;3;4;5P4, and metabolites
(as Ins1;3;4P3, for example) rather than the result of
speci¢c PtdIns-4-P-PLC activity. On other hand,
PDBu still remains able to stimulate high PtdIns-
4,5-P2-PLC activity after PMXB treatment, and
low PtdIns/PtdIns-4-P-PLC activity. Thus, we can
de¢nitely assume the existence of two phosphoinosi-
tide pathways in palisadic cells of locust rectal epi-
thelium, each mobilising di¡erent PLC and ‘PKC’
activities. It is obvious that the biological response
is under the control of a PMXB-sensitive ‘PKC’ since
we demonstrated that PMXB inhibited PtdIns/
PtdIns-4-P hydrolysis, cytosolic free Ca2 increase
Fig. 7. [3H]PDBu (10 nM) binding to PKC in microsomes from
locust rectal epithelial tissues. Experiments were carried out for
di¡erent incubation periods, in the absence of PMXB (white
points) or in the presence of PMXB (black points), and after
15 min pre-treatment with 1000 UI (Sigma). Mean þ S.E.
(n = 6^8).
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(via opening of L-type channels) and £uid resorption
[13,14,18].
The PMXB-insensitive ‘PKC’ is directly implicated
in positive feedback on PtdIns-4,5-P2-PLC activity.
Our postulate for such a new pathway generates at
least two comments. Firstly, both ‘PKC’ activities
were independent each other since PMXB did not
suppress PDBu-stimulated PtdIns-4,5-P2-PLC activ-
ity, i.e., production of Ins1;4;5P3 (Fig. 5). Whatever
the PDBu concentration, we did not record an early
increase in Ins1P1 and Ins4P1 productions, which
is interpreted as a blockage of basal PtdIns/PtdIns-4-
P breakdown. Thus, neuroparsin-induced stimulation
of each ‘PKC’ suggests either the involvement of a
chronology in DAG binding to each ‘PKC’, or the
participation of two DAG having di¡erent molecular
structures (Carricaburu and Fournier, unpublished
results) to avoid confusion in transduction of speci¢c
antidiuretic messages expressed by the agonist. On
the contrary, since PMXB totally suppressed the
early e¡ects of neuroparsin on both phosphoinositide
breakdowns, it may be supposed that other enzymes
than ‘PKC’ (and independent of this enzyme) are
mobilised by the agonist. This is not the case with
PDBu, which speci¢cally acts on ‘PKC’, and not
through receptor-G protein-PLC complex, i.e.,
when the integrity of phosphoinositide pathway
was preserved. In addition, this may suggest that
neuroparsin has probably one rather than two di¡er-
ent receptors, or requires an entire mobilisation of
the ¢rst pathway to act then on the second pathway,
via receptor and G protein.
An original ¢nding is the ability of the second
‘PKC’ (whose activity results from PtdIns-4,5-P2
breakdown) to stimulate the PLC which hydrolyses
PtdIns-4,5-P2 substrate. It has been described that
phorbol esters decrease InsP production in vertebrate
cells by either phosphorylation of receptors or GTP-
binding protein involvement [8,9], while stimulation
of phosphoinositide breakdown after a PDBu treat-
ment is rare [27,28]. Thus, such ability for ‘PKC’ to
stimulate PtdIns-4,5-P2 breakdown must be consid-
ered as an original process.
On other hand, a surprising result was obtained
after PMXB pre-treatment. The £uid resorption en-
hanced when the drug was used alone, while the
PKC inhibitor was assumed to suppress the early
PtdIns/PtdIns-4-P-PLC activity, Ca2 entry, and bio-
logical response induced by either neuroparsin or
PDBu. As a ¢rst hypothesis, we observed after
10 min of incubation in the presence of [3H]PDBu
(Fig. 7) that PMXB-treated membranes exhibited
similar [3H]PDBu binding to that showed by
PMXB-untreated membranes. This may result from
possible uncoupling of PMXB from ‘PKC’ while PS
took its place, since it was reported that PMXB com-
petes with PS for binding to the regulatory site of
PKC [29]. Thus, ‘PKC’ inhibition being lifted, the
integrity in both phosphoinositide pathways was re-
stored and, even in the presence of PMXB, some
sporadic Ca2 in£ux became possible as well as
an enhancement in PtdIns/PtdIns-4-P-PLC activity,
which produced lowly phosphorylated InsPs, as
Ins1P1, or Ins1;4P2 and Ins4P1 (Fig. 5), and
also the stimulation of £uid resorption. As a second
hypothesis, it may be supposed the involvement of a
non-phosphoinositide pathway responsible for a neg-
ative feedback on cytosolic free Ca2 in£ux, via the
participation of a soluble guanylyl cyclase [14,17,19].
We reported that antidiuretic peptides from glandu-
lar lobes of locust and cockroach corpora cardiaca
are able to stimulate rectal £uid resorption, through
cGMP- and cAMP-dependent kinases [19,20,30]. As
another explanation, possible synergy between proc-
esses evoked in both hypotheses may be also retained
to explain stimulation of £uid resorption in the pres-
ence of PMXB.
Another problem arises with treatment of locust
rectal tissues with PMXB because high Ins1;4;5P3
production (i.e., high PtdIns-4,5-P2-PLC activity)
was maintained for a long time. PtdIns-4,5-P2 break-
down generally occurs early and rapidly under a neu-
roparsin e¡ect [18]. In our experiments, Ins1;4;5P3
was slowly metabolised into lowly phosphorylated
InsPs. As an interpretation, PMXB-sensitive ‘PKC’
may control InsP turnover generated by PtdIns-4,5-
P2 breakdown. This is another argument for the ex-
istence of one rather than two receptors to bind the
neuroparsin.
Chimaerins (and Unc-13 protein) exhibit high af-
¢nity for phorbol esters, as PKC isozymes [6,7]. They
have one single cysteine-rich region with homology
to both present in PKC, and are GTPase activating
proteins for members of the Rho subfamily of small
GTP-binding proteins. A speci¢city of chimaerins is
that they require higher concentrations in phospho-
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lipid for PDBu binding than PKC, but despite these
di¡erences it appears di⁄cult to distinguish between
chimaerins and PKC in the absence of some knowl-
edge in enzyme activation as well as in their respec-
tive targets. In our model, we demonstrated that the
ATP site PKC inhibitor, bisindolylmaleimide Ro 32-
0432, not only suppressed stimulatory PDBu e¡ects
on £uid resorption as did PMXB, but also abolished
PDBu-induced stimulation of PtdIns-4,5-P2 hydroly-
sis, which was not the case with PMXB. Further-
more, we have stated that heterotrimeric GKq=11 pro-
teins and LII subtype of PtdIns-4,5-P2-PLC
participated in induction of phosphoinositide path-
way involving PMXB-insensitive ‘PKC’ (Radallah
et al., personal communication). This PMXB-insen-
sitive ‘PKC’ regulated in a classical manner the Ca2
in£ux induced by the PMXB-sensitive ‘PKC’ in-
volved in the ¢rst phosphoinositide system, via
GMPc enhancement [20]. Finally, both phorbol ester
receptors present in our model have been identi¢ed
as members of the phospholipid and Ca2-dependent
PKC family, using di¡erent techniques of chroma-
tography, autoradiography and immunological tools.
All these arguments represent some positive probes
that phorbol ester receptors involved in epithelial
cells of the locust rectum are PKC rather than chi-
maerins.
In conclusion, two PKC are present in palisadic
epithelial cells of the locust rectum. It becomes pos-
sible now to dissociate the activity of each PKC us-
ing e⁄cient pharmacological tools. One major path-
way involves a PKC able to stimulate the PtdIns-4,5-
P2-PLC which indirectly activates it, and exerts neg-
ative feedback on free-Ca2 in£ux, dependent on
PMXB-sensitive PKC, and responsible for £uid re-
sorption. Such an original pathway may be consid-
ered as a speci¢c adaptation for regulation of the
biological response, £uid resorption.
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